Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (120)

1

Discovery of Novel HIV Protease Inhibitors Using Modern Computational Techniques

enthalten in: International journal of molecular sciences | 2022

von Okafor, S. | Angsantikul, P. | Ahmed, H.

2

Atazanavir / ritonavir versus Lopinavir / ritonavir-based combined antiretroviral therapy (cART) for HIV-1 infection : a systematic review and meta-analysis

enthalten in: African health sciences | 2020

von Tigabu, B. | Agide, F. | Mohraz, M. | +1

3

HIV protease inhibitors block parasite signal peptide peptidases and prevent growth of Babesia microti parasites in erythrocytes

enthalten in: Biochemical and biophysical research communications | 2019

von Schwake, C. | Baldwin, M. | Bachovchin, W. | +7

4

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Feng, H. | Caro, L. | Fandozzi, C. | +21

5

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir

enthalten in: BMC infectious diseases | 2019

von Laker, E. | Nabaggala, M. | Kaimal, A. | +6

6

A Clinical Prediction Rule for Protease Inhibitor Resistance in Patients Failing Second-Line Antiretroviral Therapy

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2019

von Cohen, K. | Stewart, A. | Kengne, A. | +8

7

Comparative Assessment of the Magnitude of Hyperlipidemia in HIV-Infected Patients Receiving Lopinavir/r- and Atazanavir/r-Based Antiretroviral Drugs

enthalten in: Journal of the International Association of Providers of AIDS Care | 2019

von Muya, E. | Kamuhabwa, A.

8

HIV aspartyl protease inhibitors modify the percentage of activated leukocytes, as well as serum levels of IL-17A and NO during experimental leishmaniasis

enthalten in: International immunopharmacology | 2018

von Alvarenga, D. | Silva, A. | Fiuza, J. | +6

9

GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants

enthalten in: Antimicrobial agents and chemotherapy | 2018

von Delino, N. | Aoki, M. | Hayashi, H. | +7

10

Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2018

von Caniglia, E. | Phillips, A. | Porter, K. | +28

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]